Cresco Labs Inc.
Company Information
Industry
Medicinal Chemicals & Botanical Products
SIC Code
2833
Entity Type
other
SEC Category
Emerging growth company
State of Incorporation
British Columbia, Canada
Business Address
600 W. FULTON STREET, SUITE 800, CHICAGO, IL, 60661
Mailing Address
600 W. FULTON STREET, SUITE 800, CHICAGO, IL, 60661
Phone
(312) 929-0993
Fiscal Year End
1231
EIN
981505364
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 40-F Canadian company annual report | March 6, 2026 | View on SEC |
| 6-K Foreign company current report | February 2, 2026 | View on SEC |
| 6-K Foreign company current report | November 7, 2025 | View on SEC |
| 6-K Foreign company current report | September 22, 2025 | View on SEC |
| 6-K Foreign company current report | September 17, 2025 | View on SEC |
| 6-K Foreign company current report | August 15, 2025 | View on SEC |
| 6-K Foreign company current report | August 7, 2025 | View on SEC |
| 6-K Foreign company current report | June 13, 2025 | View on SEC |
| 6-K Foreign company current report | May 30, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | May 15, 2025 | View on SEC |
Annual Reports
40-F
March 6, 2026
- Potential federal rescheduling of cannabis to Schedule III could eliminate 280E taxation, significantly boosting profitability and cash flow.
- Generated strong positive operating cash flow of $73 million and Free Cash Flow of $38 million in 2025, demonstrating financial resilience despite a net loss.
Related Companies
Companies in the same industry (SIC: 2833)
HEALTHY EXTRACTS INC.
HYEX
Medicinal Chemicals & Botanical Products
MANNATECH INC
MTEX
Medicinal Chemicals & Botanical Products
Synergy CHC Corp.
SNYR
Medicinal Chemicals & Botanical Products
Tilray Brands, Inc.
TLRY
Medicinal Chemicals & Botanical Products
Charlie's Holdings, Inc.
CHUC
Medicinal Chemicals & Botanical Products
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.